Atlas Trials

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

Clinical trial NCT00001830 · COMPLETED

Trial details

NCT number
NCT00001830
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHodgkin's DiseaseMultiple MyelomaNon Hodgkin's Lymphoma
Start date
1999-07-20
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.